Hehuang Pharmaceutical (00013) granted a total of 1.493,400 share options

Zhitongcaijing · 06/10 10:17

Zhitong Finance App News, Hehuang Pharmaceutical (00013) issued an announcement to grant Dr. Su Weiguo (Executive Director, CEO and Chief Scientific Officer) (that is, a person who performs administrative duties in accordance with the British Market Abuse Regulations (“person performing administrative duties”)), subject to performance targets; subject to acceptance by the grantor, to subscribe for 1.493,400 common shares with a face value of 0.10 US dollars per share.